Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Cellyan Biotechnology Co., Ltd (HKPD) had Cash Flow from Financial Activities of $-0.63M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$12.33M |
|
$0.24M |
|
$0.32M |
|
$12.84M |
|
$3.20M |
|
$0.07M |
|
$0.07M |
|
$3.26M |
|
$9.58M |
|
$9.51M |
|
$9.58M |
|
-- |
|
| Cash Flow Statement Financials | |
$-0.75M |
|
$0.86M |
|
|
Cash Flow from Financial Activities |
$-0.63M |
$0.75M |
|
$0.22M |
|
$-0.53M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|